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Introduction
Mycoplasmas are prokaryotic organisms within the class 
Mollicutes.1 The absence of a cell wall can affect their 
survival outwith the host environment and special cul-
ture techniques are often required to identify these slow-
growing organisms. Few laboratories regularly identify 
the species involved as, until recently, this required labo-
rious and subjective biochemical and immunological 
testing of cultured organisms.2–4 In addition, appropriate 
antibacterial susceptibility testing is not widely available 
for Mycoplasma species.2
Mycoplasma species are often considered commensal 
organisms of mucosal membranes, with a number of 
species identified from the upper respiratory tracts of 
healthy cats, including Mycoplasma felis, Mycoplasma 
gateae, Mycoplasma feliminutum and Mycoplasma arginini.2 
Mycoplasma species are not generally considered to be 
present in the lower airways of healthy cats.5,6 Studies in 
the USA and Australia have suggested that approxi-
mately 22% of cats with lower airway disease may 
have a concurrent Mycoplasma species infection.5,7 The 
species of Mycoplasma involved in both studies was not 
identified.
Prior to this study, clinical perception at our establish-
ment was that Mycoplasma species were rarely identified 
in lavage fluid from cats with lower airway disease. The 
primary aim of this study was to assess whether the 
prevalence of Mycoplasma species infection was, indeed, 
lower in cats from Scotland and Northern England 
than in Australia and the USA by means of a retro-
spective study. Results of this study subsequently led to 
a prospective study to investigate whether alternative 
methods of sample collection and assay could improve 
identification of this organism. The hypothesis was that 
use of a Mycoplasma species transport medium and/or a 
polymerase chain reaction (PCR) test to identify 
Mycoplasma species would enable better detection of 
these organisms in bronchoalveolar lavage (BAL) fluid.
Materials and methods
Retrospective study — case selection
The Veterinary Database at the University of Edinburgh 
Hospital for Small Animals (UoE-HFSA) was searched 
for feline patients that had undergone investigation of 
lower airway disease between 1 July 1999 and 1 July 
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2005. Inclusion criteria for the study were performance 
of BAL with culture of the lavage fluid. Exclusion criteria 
were missing or incomplete records. Records were eval-
uated for signalment, presenting problem(s) relating to 
the lower respiratory tract (cough, wheeze and/or dysp-
noea), radiological findings, lavage fluid culture and 
cytology, and primary diagnosis. A diagnosis of asthma 
was based on a normal or predominantly bronchial radi-
ographic lung pattern, BAL fluid where eosinophils 
comprised >25% of the nucleated cells, and response to 
treatment with corticosteroids and/or bronchodilators. 
A diagnosis of chronic bronchitis was based on a normal 
or predominantly bronchial radiographic lung pattern, 
BAL fluid containing predominantly neutrophils, and 
response to treatment with corticosteroids and/or bron-
chodilators. Bronchopneumonia was diagnosed on the 
basis of a bronchial or alveolar radiographic lung pat-
tern, a BAL fluid containing predominantly neutrophils, 
positive bacterial culture or identification of an infec-
tious agent, and response to therapy with antibacterials. 
The cases with positive BAL culture results were chosen 
for further review.
Prospective study — case selection
Feline patients referred to the UoE-HFSA for investiga-
tion of lower airway disease were recruited into the 
study from 1 July 2005 to 1 July 2008. Inclusion criteria 
included history of cough, wheeze and/or dyspnoea. 
Cases were excluded if they had received antibiotics 
within 1 week of presentation or where the case file 
could not be retrieved. Diagnostic procedures comprised 
those normally undertaken for clinical evaluation of 
these cases, namely: routine haematology and serum 
biochemistry, thoracic radiography and BAL (± bron-
choscopy at the attending clinician’s discretion). 
Additional tests performed in the prospective study 
comprised evaluation of each patient for feline leukae-
mia virus (FeLV) and feline immunodeficiency virus 
(FIV), and extended testing of the BAL fluid for 
Mycoplasma species by means of transport media and a 
PCR assay.
Diagnostic investigations — both  studies
Samples were submitted to the University of Edinburgh 
Veterinary Pathology Unit (VPU) and Veterinary 
Microbiology Laboratory (VML) for further evaluation.
Haematology analysis was performed using a 
Pentra 60 haematology analyser (ABX Diagnostics). 
Biochemistry was performed on an opeRA autoanalyser 
(Bayer Diagnostics). Electrolytes were measured using 
an AVL 9180 Electrolyte Analyser (AVL Scientific 
Corporation).
Further investigations were performed with the 
patients under general anaesthesia. Orthogonal radio-
graphs (right lateral and ventro-dorsal views) were 
taken with positive pressure ventilation to facilitate opti-
mal inspiratory views. Bronchoscopy was performed, 
dependent on the clinician’s assessment. Bronchoalveolar 
lavage was performed by passing a sterile 172 cm end-
opening endoscopy catheter (Portex) down the lumen of 
the sterile endotracheal tube until it lodged blindly 
within a bronchus. Three aliquots of 3 ml warmed, ster-
ile saline were used to lavage the airway, with recovery 
by syringe aspiration, following brief coupage of the tho-
rax. Quantification of recovery volume was not per-
formed. The recovered BAL fluid was pooled within a 
plain, sterile tube, before decanting 0.5–1 ml aliquots for 
further assessment.
One 0.5 ml sample of the BAL fluid was submitted 
in an ethylenediamine tetra-acetic acid (EDTA) tube 
for cytological assessment by the VPU. Following cen-
trifugation at 1500 rpm (224g) for 5 mins (Thermo 
Fisher Cytospin III), the cytospin was stained with 
May-Grunwald Giemsa stain. The smear was evalu-
ated for the presence of oral contamination (eg, squa-
mes ± Simonsiella species) and evidence of bacterial 
infection (eg, intracellular bacteria), and the percent-
age of cell populations was calculated.
A second 1 ml aliquot was submitted in a plain tube 
for bacteriological culture. An anaerobic environment 
was not maintained, but samples were submitted to the 
VML within 4 h of collection. In addition to routine aero-
bic and anaerobic culture, the BAL fluid was inoculated 
on to a blood agar plate and incubated at 37ºC with 10% 
CO2 for 5 days for the culture of Mycoplasma species. 
While this would identify Mycoplasma species within 
72 h if organisms were present in large numbers, the 
fluid was also inoculated into mycoplasma broth 
(CM0403; Oxoid) supplemented with penicillin, thallous 
acetate, yeast extract and horse serum (SR0059; Oxoid). 
The broth was incubated at 37ºC with 10% CO2 for 
5 days after which it was transferred to mycoplasma 
agar (CM0401; Oxoid) supplemented as above and incu-
bated as before for a further 5 days. This was to ensure 
that small numbers of organisms could be isolated. 
Positive cultures would be checked microscopically 
using Diene’s Stain.
Diagnostic investigations — prospective study only
Blood was tested for FeLV antigen and FIV antibody by 
an in-house enzyme-linked immunosorbent assay 
(SNAP FIV/FeLV Combo; Idexx Laboratories).
A 1 ml aliquot of the BAL fluid was submitted for bac-
terial culture to the VML in a transport medium appro-
priate for Mycoplasma species culture (M4 Microtest tube; 
Remel). A further 1 ml aliquot of this fluid was submit-
ted to the Animal Health and Veterinary Laboratories 
Agency, Weybridge, for identification of Mycoplasma 
species by PCR and denaturing gradient gel electropho-
resis, as previously reported by McAuliffe et al.8 Briefly, 
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DNA was extracted from the BAL fluid using a Genelute 
genomic DNA kit (Sigma), according to the manufactur-
er’s instructions. Amplification of DNA was achieved by 
means of a universal bacterial primer GC-341F and a 
specific reverse primer for Mollicutes (R543). Cycling 
conditions comprised denaturation at 94°C for 5 mins, 
then 30 cycles of 95°C for 1 min, 56°C for 45 s and 72°C 
for 1 min, followed by an extension step of 72°C for 10 
mins, using a gradient thermocycler (iCycler; Bio-Rad). 
Samples were then transferred to polyacrylamide/bis 
(37.5:1) gels with denaturing gradients from 30% to 60% 
[where 100% is 7M urea and 40% (v/v) deionised forma-
mide] in 1 × Tris-acetate-EDTA electrophoresis buffer. 
Following electrophoresis, gels were stained with SBYR 
Gold (Cambridge BioScience) and visualised with 
ultraviolet illumination. Bands identified on the gel were 
compared with reference species to enable identification 
of species identified from the clinical cases (see Figure 1).
Statistical analysis
Findings were tabulated in a spreadsheet (Microsoft 
Excel for Windows). Statistical analysis was performed 
with a commercial software programme (Minitab 15; 
Minitab). Continuous data were analysed for 
normality and expressed as mean (± standard devia-
tion). Prevalence data are given as percentage popula-
tion and confidence intervals (CI) were generated by 
means of a test for one proportion, with the α-level set at 
0.05. This test was also used to investigate the alternate 
hypothesis that disease prevalence within this study dif-
fered from previous studies, with statistical significance 
set at P <0.05.
Results
Retrospective study
From the UoE-HFSA database, 55 feline cases were iden-
tified as having had a BAL and culture performed. Of 
these 55 cases, the records could not be found for five 
cases, and these cases were thus excluded. The remain-
ing 50 cases comprised 28 neutered males and 22 neu-
tered females. Ages ranged from 6 months to 16 years 
with a mean age of 6.39 years (SD ± 4.31). The majority of 
cats were domestic shorthair cats (n = 28), with the fol-
lowing breeds also represented: Siamese (n = 7), Bengal 
(n = 3), Maine Coon (n = 2), Persian (n = 2), Burmese (n = 
2) and one each of Abyssinian, Balinese, British Shorthair, 
Korat, Oriental and Somali.
A diagnosis of asthma was made in 23 cases and bron-
chitis in one case, giving an overall prevalence of 48% for 
lower airway disease. Concurrent disease was identified 
in seven of these cases, comprising infection (n = 3), 
hypertrophic cardiomyopathy (n = 2), laryngeal lym-
phoma (n = 1) and hyperthyroidism (n = 1). Although 
four cases had positive bacterial cultures from the BAL 
fluid, in one case, where low numbers of mixed bacteria 
were cultured, this was considered contamination (see 
Table 1). Bronchopneumonia was diagnosed in 13 cases, 
but positive cultures only obtained in four BAL samples 
(see Table 1). Mycobacterial infection was confirmed in 
two cases and suspected in a third, herpesvirus and tox-
oplasmosis comprised one case each and no organism 
was identified in four cases, including one case of lobar 
pneumonia. The remaining cases comprised rhinitis (n = 
5), pulmonary adenocarcinoma (n = 2) idiopathic pul-
monary fibrosis (n = 1), nasal adenocarcinoma (n = 1) 
nasopharyngeal stenosis (n = 1) and retropharyngeal 
mass (n = 1). The cases with primary upper airway dis-
ease also had radiographic changes suggestive of lower 
airway disease, hence their inclusion in the study. No 
diagnosis was given in two cases.
Figure 1 PCR-DGGE gel from feline control samples.  
Lane 1 - Mycoplasma felis; Lane 2 - Mycoplasma feliminutum; 
Lane 3 - Mycoplasma gateae; Lane 4 - Mycoplasma arginini
 by guest on April 5, 2014jfm.sagepub.comDownloaded from 
836 Journal of Feline Medicine and Surgery 14(12)
Bacteria were cultured from 10 of the cases (see Table 1), 
giving a prevalence of 20% (CI: 10.0–33.7%). In one of 
these cases, a small number of a mixed population was 
suggestive of contamination and, in a second cat, the 
identification of Staphylococcus aureus was suggestive of 
extension of nasopharyngeal disease. Pasteurella species 
was the most commonly identified infectious agent (four 
cases), and Mycoplasma species were not identified in 
any case (0%: CI 0.0–5.8%).
Prospective study
During the prospective study, 30 cases presented to the 
UoE-HFSA with a history of cough, wheeze and/or 
dyspnoea. For two of these cases, the files could not be 
found, and for a further two, the cats had received antibi-
otics in the week prior to presentation; these four cases 
were excluded. One cat presented for investigation on 
three occasions; therefore, although 26 cases were 
assessed, this represented only 24 cats. Eleven cats were 
neutered females, with one entire male and 12 neutered 
males. Ages ranged from 6 months to 18 years with a 
mean age of 8.86 years (SD ± 4.20). This was significantly 
older (P = 0.02) than the population in the retrospective 
study. As before, the majority of cats were domestic short-
hair cats (n = 13), with other breeds represented as fol-
lows: Siamese (n = 3), Oriental (n = 2) and one each of 
domestic longhair, Devon Rex, Maine coon, Persian, 
Ragdoll and Russian Blue.
The majority of cases (15/26; 57.7%) were diagnosed 
with lower airway disease [bronchitis (n = 5) or asthma 
(n = 9)] based on a diffuse bronchointerstitial radio-
graphic pattern, negative culture and predominance of 
eosinophils (asthma) or non-degenerate neutrophils 
(bronchitis) on BAL fluid. Pneumonia or bronchopneu-
monia was diagnosed in six cases and pulmonary neo-
plasia in one and suspected in a second. Four cats 
presented with signs of upper airway disease (sneeze or 
stertor) in addition to coughing and wheezing. In two 
cases this was associated with a final diagnosis of 
asthma. One cat was diagnosed with lipoid pneumonia 
following inhalation of liquid paraffin.
Lymphopenia was the most commonly identified hae-
matological abnormality (13/26), followed by neutro-
philia (4/26) and eosinophilia (3/26). All three cats with 
peripheral eosinophilia were diagnosed with asthma. 
Three cats also had neutropenia, which is an unusual 
finding in respiratory disease. In one case it was attrib-
uted to increased tissue demand associated with broncho-
pneumonia and, in a second case, the value was only 
marginally below the reference interval and thus clini-
cally insignificant. For the third case that exhibited a more 
significant neutropenia, no explanation was found. Mild 
thrombocytopenia and monocytosis were each docu-
mented in one case. Elevations in blood glucose (<15 
mmol/l) were present in 50% of cats and consistent with 
stress hyperglycaemia. Elevated urea was documented in 
8/26 cases and elevated creatinine in 5/26 cases. 
Hypokalaemia was also identified infrequently (4/26). 
No cats were positive for FeLV antigen or FIV antibody.
None of the BAL fluid samples showed evidence of 
oral contamination. Routine culture was positive in only 
two cases of bronchopneumonia (7.69%; CI 0.94–25.1%), 
yielding Moraxella species in one cat and Pasteurella spe-
cies in a second. Mycoplasma species were not cultured, 
either from direct culture, or when the transport medium 
was employed (0%; CI 0.0–10.9%). Mycoplasma species 
PCR was positive on four occasions (15.4%; CI 4.36–
34.9%), but this was not statistically significant com-
pared with prevalence obtained by culture (P = 0.11). In 
the four cases that were found to be positive by PCR, 
three different species of Mycoplasma species were iden-
tified (see Table 2). The case in which M feliminutum spe-
cies was identified was also the case from which 
Moraxella species was cultured. Two cases occurred in 
the same cat, with different species (M gateae and M felis) 
being isolated on two separate occasions, 4 months 
apart. On its third presentation, Pasteurella species was 
isolated from this cat. In the fourth case, M felis was iden-
tified by PCR (see Figure 2).
In total (combining the results from the retrospective 
and prospective studies), culture for bacteria was posi-
tive in 12/76 cases (15.79%; CI 8.43–25.96%) and 
Table 1 Retrospective study: cases with a positive bronchoalveolar lavage fluid culture
Breed Age (years) Gender Diagnosis Organism cultured
Korat 10 FN Bronchopneumonia Actinomyces
Siamese  3 FN Asthma Chryseobacterium indolgenes
Siamese 12 MN Asthma Pasteurella species
DSH 11 FN Asthma; laryngeal lymphoma Gram-negative bacilli
DSH  9 MN Not obtained Pasteurella multocida
Persian  8 FN Nasopharyngeal stenosis Staphylococcus aureus
DSH  8 MN Bronchopneumonia Pasteurella multocida
DSH  3 FN Asthma Mixed growth; small numbers
DSH 11 MN Bronchopneumonia; renal lymphoma Corynebacterium
DSH  6 MN Bronchopneumonia Pasteurella multocida
DSH = domestic shorthair, FN = female neutered, MN = male neutered
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Mycoplasma species culture was negative in all cases (0%; 
CI 0.00–3.68%). When comparison was made between 
the population in the retrospective study and the pro-
spective study, there was no significant difference in the 
number of BAL cultures that were positive for bacteria 
(P = 0.107) or Mycoplasma species (P = 1.000).
Discussion
Mycoplasma species have been reported as a cause of 
feline pneumonia and pyothorax.9–13 Randolph et al5 
recovered Mycoplasma species in 21.4% (6/28) of tracheo-
bronchial lavage samples from cats with pulmonary dis-
ease, using both a Hayflick medium with 15% horse 
serum and 20% porcine serum agar plates, and broth 
incubated at 35.5°C at 8% CO2 and 100% humidity.14 
Foster et al7 identified Mycoplasma species in 22.4% 
(15/67) of cases, based on negative Gram-staining of 
BAL cytology and colonial morphology in aerobic cul-
ture of sheep blood agar at 37°C. In a study by Moise 
et al,15 Mycoplasma species were present in 4/9 (44%) of 
cases tested, but the culture method employed was not 
described. In marked contrast, the current study failed to 
identify Mycoplasma species infection in 76 cases of feline 
lower airway disease when bacterial culture was 
employed, even when, in 30 cases, a mycoplasma trans-
port medium was included. There are a number of pos-
sible explanations for this discrepancy in prevalence 
between the studies.
The first is that Mycoplasma species are genuinely 
infrequently present in the lower airways of cats in our 
referral population from Scotland and the North of 
England. Geographic discrepancies for Mycoplasma 
infections affecting other species, such as farm animals, 
have not been documented; however, to our knowledge, 
prevalence studies for Mycoplasma species infection in 
cats (other than the haemotropic Mycoplasma species) 
have not been performed in the UK.
Different techniques employed in the various studies 
could have contributed to the different outcomes docu-
mented — the  highest detection levels were in a study 
employing cytological brush technique rather than 
BAL.15 Direct comparison of techniques among the three 
BAL studies is limited by the absence of detail of some 
Table 2 Prospective study: cases with a positive bronchoalveolar lavage fluid Mycoplasma PCR
Breed Age (years) Gender Diagnosis Mycoplasma 
species
Antibacterial
DSH  6 FN Bronchopneumonia M feliminutum Doxycycline
Oriental  9 MN Bronchopneumonia M gateae Marbofloxacin
Oriental  9 MN Bronchopneumonia M felis Azithromycin
 Doxycycline
Devon rex 10 MN Eosinophilic rhinitis M felis Doxycycline
 Asthma  
DSH = domestic shorthair, FN = female neutered, MN = male neutered
Figure 2 PCR-DGGE gel from case positive for Mycoplasma 
felis. Lane 1 - sample from case; Lane 2 - negative sample; 
Lane 3 - reference sample Mycoplasma felis
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aspects in the previous studies; that said, some potential 
differences are considered below.
Contamination of BAL fluid from the upper airways 
could lead to increased recovery of Mycoplasma species, 
as these organisms are considered commensals of the 
upper airways.6 In one study5 an intravenous catheter 
was used for sampling, as described by Moise and Blue.16 
This was extended blindly beyond the endotracheal tube 
and may, therefore, have resulted in sampling from the 
trachea or tip of the endotracheal tube rather than the 
lower airways. However, the technique employed in 
the second study7 was similar to the current study, 
making the BAL technique unlikely to account for the 
different results.
The death of viable organisms in transit prior to cul-
ture is potentially supported by the finding of Mycoplasma 
species DNA in the samples tested by PCR, with a preva-
lence of 15.4% — not dissimilar to the earlier studies. 
Mycoplasma species organisms can be short-lived outside 
the host17 and failure to ensure an anaerobic environment 
by incompletely filling sample tubes may have resulted 
in the loss of viability of organisms. However, incorporat-
ing a mycoplasma transport medium into the prospec-
tive study did not improve recovery of these organisms, 
suggesting that death in transit to the microbiology labo-
ratory was unlikely to be a factor. Transit times to the 
microbiology laboratories appeared similar in all three 
studies and are likely to be considerably less than those 
achievable in the general practice situation where post-
age to an external laboratory is likely to be required.
Suboptimal culture technique was considered as a 
possible explanation for the lack of recovery of 
Mycoplasma species organisms. Direct comparison with 
culture media employed in the previous studies was not 
possible, although one study7 did not use a specific 
Mycoplasma species culture medium yet still cultured 
Mycoplasma species more frequently than in the present 
study. The culture medium used in the current study 
was a modified Hayflick medium (B); however, different 
Mycoplasma species media are available and there is no 
ideal medium that suits all Mycoplasma species. A differ-
ent modified Hayflick medium (N) may be more suitable 
for culture of M felis; M feliminutum is a more fastidious 
organism that may grow better on SP4 medium.18 Our 
results may reflect different requirements by different 
species of Mycoplasma and could explain why the species 
identified in the current study may have grown poorly 
on the media employed. Suboptimal culture media may 
result in low numbers of small colonies that may be dif-
ficult to detect. Incorporation of an indicator such as glu-
cose or arginine that is fermented and gives rise to a 
colour change with phenol may also be beneficial. Other 
factors affecting culture could be variation in media 
components and preparation, environmental growth 
conditions and the duration of incubation.18
Treatment of the cats with antibacterial agents prior to 
referral for examination is, perhaps, the most likely 
explanation for the inability to culture viable organisms, 
while still being able to detect residual Mycoplasma spe-
cies DNA. Although cats that had received antibacterial 
therapy within the previous week were excluded from 
the study, further review of the cases identified that 17 
cases (65%) had received antibacterial drugs in the 3 
months prior to investigation. The antibacterial agents 
most frequently used were doxycycline (seven cases), 
amoxicillin- clavulanate (five cases), enrofloxacin (four 
cases) and one each of cephalosporin, metronidazole and 
clindamycin. Some cats had received more than one 
antibiotic.
The use of doxycycline and enrofloxacin could have 
compromised our ability to culture Mycoplasma species; 
the high number of cats that had received antibacterial 
drugs may also explain the identification of bacterial 
infection in only 2/26 cases. This prevalence (7.6%) is 
much less than the 24–48% reported previously in a 
number of studies7,15,19,20 and also less than the 33% 
reported in a study in healthy cats.6 This may reflect 
increased awareness of the potential role of bacterial 
organisms in feline respiratory disease by general practi-
tioners and increased use of antibacterial agents com-
pared with when the earlier studies were performed.
It is of note that during the prospective study, one pos-
itive case of Mycoplasma species was cultured, although 
this case had been excluded from the study as it had 
received prior antibacterial therapy (marbofloxacin). 
Both the direct sample and the transport media sample 
cultured positive, indicating that the Mycoplasma species 
culture technique was appropriate in this case, but 
possibly dependent on bacterial numbers or Mycoplasma 
species present. Unfortunately, PCR testing was not per-
formed on this sample to identify which species was 
involved. The ability to only culture Mycoplasma species 
in one case that had been excluded is a severe limitation 
of this study. Concurrent submission of samples to more 
than one bacteriology laboratory for culture would have 
helped to address some of the questions raised about the 
importance of different culture techniques.
As a result of the problems identified with culture 
requirements for Mycoplasma species, this study suggests 
that assessment of Mycoplasma species infection by PCR 
may be a more sensitive method of detection of these 
organisms. This is in contrast to the study by Johnson et 
al17 that identified good agreement between culture and 
PCR for detection of Mycoplasma species in samples 
obtained from the nasal cavities of cats. Use of species 
PCR has a number of advantages: it is able to detect fas-
tidious or non- cultivable organisms, and can do so more 
rapidly than standard culture techniques; it is not 
affected by death of organisms in transit, as may occur 
with submissions from general practice; and it allows 
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the species involved to be identified. However, if the 
organism is not cultured, and only DNA is detected, the 
significance of that organism in causing infection at the 
site from which it is isolated is questionable. Low levels 
of contamination from the oral cavity, for example, may 
have been detected by PCR, but not by culture. This 
could have been addressed by performing Mycoplasma 
species PCR on BAL fluid from cats that were not suffer-
ing from lower airway disease to try to evaluate further 
the role of these organisms in lower airway disease. 
However, performance of BAL on healthy cats would be 
considered an experimental procedure in the UK neces-
sitating a Home Office Licence.
Antimicrobial choices for Mycoplasma species infec-
tions are limited by difficulties in performing culture 
and sensitivity analysis, although guidelines have been 
produced for minimal inhibitory concentration testing.18 
Generally, Mycoplasma species are considered sensitive 
to macrolides, tetracyclines, chloramphenicol, fluoroqui-
nolones, lincosamides and aminoglycosides, but are 
resistant to beta-lactam antibiotics, as they do not pos-
sess a cell wall.1 Different antibacterial choices were 
employed to manage the cases positive for Mycoplasma 
species by PCR. The first case with Moraxella species and 
M feliminutum was prescribed doxycycline for 21 days, 
but required on-going management with salbutamol 
and fluticasone inhalers for lower airway disease. The 
second case, with M gateae infection, was prescribed a 
21-day course of marbo floxacin initially and although 
clinical signs initially improved, recurrence of signs 4 
months later was associated with isolation of M felis. 
This did not respond initially to 2 weeks of treatment 
with azithromycin, but improved when doxycycline was 
prescribed. As the latter medication was prescribed by 
the referring veterinary surgeon, it is unclear how long a 
course was prescribed. The fourth case was associated 
with M felis infection and responded to treatment with 
doxycycline for 30 days, although on-going problems 
with eosinophilic rhinitis remained. While these cases 
improved with antibacterial therapy, concurrent treat-
ment with other drugs, such as bronchodilators or corti-
costeroids, makes it impossible to be conclusive about 
the role of infection in these cases.
Two cases demonstrated a lack of response to certain 
antibacterials. In addition to the M felis case not respond-
ing to azithromycin, the culture-positive case had been 
excluded because it had received marbofloxacin within 
1 week of being evaluated. This is consistent with find-
ings in a previous study,21 where doxycycline was inef-
fective in one case, two cases failed to respond to 
enrofloxacin and one case failed to respond to clinda-
mycin. Interestingly, two cases in that study responded 
well to azithromycin, whereas in the current study this 
antibiotic was found to be ineffective in the one case in 
which it was used. Unfortunately, too few positive cases 
were identified in this study to speculate on associations 
between antibacterial resistance and the species of 
Mycoplasma. This is an area that warrants further 
exploration.
No association with Mycoplasma species infection and 
positive retroviral status was identified despite an asso-
ciation between immunocompromise and Mycoplasma 
species infection having been identified in humans.22
Conclusions
This study highlights the difficulties encountered in the 
recovery of Mycoplasma species from within the lower 
airways of cats. The prevalence of Mycoplasma species 
infection detected by PCR was 15.4%, which is lower 
than that detected in previous studies where bacterial 
culture was employed. This may reflect more frequent 
use of antibacterial agents by general practitioners in the 
management of feline lower airway disease. While the 
clinical significance of identifying Mycoplasma species 
DNA alone remains in doubt, the use of PCR will allow 
for future studies to investigate more fully the species of 
Mycoplasma involved in feline respiratory disease and 
will help to identify species variation in susceptibility to 
antibacterial drugs. To our knowledge this is the first 
time M feliminutum has been documented in association 
with lower respiratory tract disease in the cat.
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